Variability of the factor VIII response to DDAVP in a large kindred with mild haemophilia A

Haemophilia

Volumn 3, Issue 4, 1997, Pages 259-264

  Ravnsbaek Jensen A ^a   Ingerslev, J ^a   Knudsen, L ^a   Fredberg, U ^a   Scheibel, E A ^b   Schwaab, R ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c Dept Exp Haematol Transfus Med ^*  (Germany)

Author keywords

DDAVP; Desmopressin acetate; Factor VIII; Haemophilia A; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEMOPHILIA A; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030688999     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1997.00115.x     Document Type: Article

References (16)

1. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-Deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 1977; 869-72.
2. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Brit J Haemotol 1981; 47: 283-93.
3. Mannucci PM, Åberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Brit J Haemotol 1975; 30: 81-93.
4. Ludham CA, Peake IR, Alien N, Davies BL, Furlong RA, Bloom AL. Factor VIII and fibrinolytic response to deamino-8-D-arginine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Brit J Haemotol 1980; 45: 499-511.
5. Holmberg L, Mannuci PM, Tuersson I, Ruggeri ZM, Nilsson IM. Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia. Scand J Haemotol 1974; 13: 33-8.
6. MacGregor IR, Roberts EM, Prowse CV, Broomhead AF, Ozolins M, Litka P. Fibrinolytic and Haemostatic Responses to Deamino-D-Arginine Vasopressin (DDAVP). Administration by intravenous and Subcutanous Routes in Healthy Subjects. Thromb Haemostasis 1988; 59 (1): 34-9.
7. Mannuci PM, Bettega D, Cattaneo M. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Brit J Haemotol 1992; 82: 87-93.
8. Rodeghiero F, Castaman G, Bona ED;, Ruggeri M. Consistency in response to repeated DDAVP infusions in patients with von Willebrand's disease and haemophilia A. Blood 1989; 74: 1997-2000.
9. Mazurier C, Gaucher C, Jorieux S, Goudemand M. Biological effect of desmopressin in eight patients with type 2 N ('Normandy') von Willebrand's disease. Collaborative Group. Br J Haematol 1994; 88: 849-54.
10. Schwaab R, Oldenburg J, Schwaab U, Johnson DJD, Olek K, Brackman HH, Tuddenham EDG. Characterization of mutations within the factor VIII gene in 73 unrelated mild and moderate haemophiliacs. Brit J Haematol 1995; 91: 458-64.
11. del Fuente B, Kasper C, Rickles FR, Hoyer LW. Response of patients with mild and moderate haemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Int Med 1985; 103: 6-14.
12. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWF. Ag). Scand J Clin Lab Invest 1987; 47: 143-9.
13. Peerlink K, Eikenbom JCJ, Ploos van Amstel HK, et al. A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg 854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol 1992; 80: 358-63.
14. Ingerslev J, Bukh A, Møller NPH, Stenbjerg S, Zeuthen J. Applications of immunoperoxidase techniques in specificity testing of monoclonal antibodies (MAbs) against von Willebrand factor (vWf). Clin Chim Acta 1988; 174: 65-82.
15. Lethagen S, Harris AS, Sjørin E, Nilsson IM. Intranasal and intravenous a dministration of Desmopressin: effect on FVIII/vWF, pharmacokinetics and reproducibility. Thromb Haemostas 1987; 58: 1033-6.
16. Lethagen S, Egervall K, Berntorp E, Bengtsson B. The administration of desmopressin by nasal spray: a dose-determination study in patients with mild haemophilia A or von Willebrand's disease. Haemophilia 1995; 1: 97-102.